Home / TGFBR3L Knockout Cell Lines

TGFBR3L Knockout Cell Lines

Gene: TGFBR3L

Official Full Name: transforming growth factor beta receptor 3 likeprovided by HGNC

Gene Summary: Predicted to enable glycosaminoglycan binding activity; transforming growth factor beta receptor activity; and type II transforming growth factor beta receptor binding activity. Predicted to contribute to transforming growth factor beta binding activity. Predicted to be involved in several processes, including epithelial to mesenchymal transition; regulation of transforming growth factor beta receptor signaling pathway; and transforming growth factor beta receptor signaling pathway. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO13441 TGFBR3L Knockout cell line (HeLa) Human TGFBR3L 1:3~1:6 Negative Online Inquiry
KO13442 TGFBR3L Knockout cell line (HCT 116) Human TGFBR3L 1:2~1:4 Negative Online Inquiry

Background

TGFBR3L Gene Knockout Cell Lines are genetically modified cellular models that facilitate the study of the transforming growth factor-beta (TGF-β) signaling pathway by effectively eliminating the expression of the TGFBR3L gene. This gene encodes the TGF-β receptor type III-like protein, which plays a crucial role in the modulation of cellular responses to TGF-β—an important cytokine involved in numerous cellular processes including proliferation, differentiation, and apoptosis. By knocking out TGFBR3L, researchers can investigate the downstream effects of impaired TGF-β signaling on cell behavior and function.

The key mechanism behind these cell lines lies in the use of CRISPR/Cas9 technology, a powerful genomic editing tool that enables precise alterations to the DNA sequence of target genes. Following the knockout, the resulting cell lines demonstrate altered responses to TGF-β, thereby serving as an invaluable resource for understanding the implications of disrupted TGF-β signaling in various biological contexts, such as fibrosis, cancer progression, and immune regulation.

In both research and clinical settings, these cell lines provide essential insights into disease mechanisms and potential therapeutic interventions. The significant scientific importance of TGFBR3L knockout models lies in their ability to support drug discovery efforts, validate biomarkers, and elucidate the role of TGF-β signaling in pathophysiological processes.

Compared to traditional methods of study that rely on wild-type cells or non-targeted gene editing, our TGFBR3L Gene Knockout Cell Lines offer unmatched specificity, reproducibility, and physiological relevance. They empower researchers to delineate the causal relationships between TGF-β signaling and cellular outcomes with greater precision.

For researchers, clinicians, and pharmaceutical developers looking to gain a deeper understanding of TGF-β-mediated pathways, these knockout cell lines represent an essential tool that enhances experimental rigor. Our company leverages years of expertise in genetic engineering and cell biology, ensuring that our products meet the highest standards of quality and reliability to support your vital research initiatives.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.